2 For a 505(b)(2) sponsor, these new indications represent a value continuum where they can repurpose an established molecule for a specialized population with much lower risk
How long should I taper off semaglutide or other GLP-1 medications
Invest 126: 195-206 (2015)
Mohans Diabetes Specialities Centre, said "This data reinforces oral semaglutides groundbreaking role as the first and only approved oral glucagon-like peptide-1 receptor agonist (GLP-1 RA) to achieve a significant reduction in cardiovascular risk within this high-risk population
Crucially, BPC 157 might act as the particular peptidergic agent that implements the cytoprotective capabilities, and pleiotropic beneficial effects [1,3,4,5,6,9,32,33,34,92] (as noted above, largely involving the muscle healing and function recovery of striated, smooth and heart muscle) [1,3,4,5,6,9,32,33,34,92]
This discrepancy may be due to the different mechanisms employed by different inhibitors to inhibit MEK1/2 activity, which requires further investigations
